Literature DB >> 25478417

A rare case of acute lymphoblastic leukaemia in pregnancy- unique maternal-fetal challenges.

Shamim Khandaker1, Shabana Munshi2.   

Abstract

Leukaemia in pregnancy is rare and lethal. Its incidence is estimated to be 1 in 75,000 pregnancies. Use of chemotherapeutic agents during pregnancy can give rise to maternal and fetal adversity; resulting in dilemma regarding proper management plan. A 25-year-old pregnant lady was presented at 24 wk of gestational age with cervical and inguinal lymphadenopathy and bicytopenia in complete blood counts. Diagnosis of acute lymphoblastic leukaemia was confirmed by bone marrow biopsy. Treated with appropriate chemotherapeutic regimen with some modification in the standard protocol due to pregnancy and delivered successfully by lower segment caesarean section at 34 wk of gestational age. Diagnosis of acute leukaemia during pregnancy need high index of suspicion and need prompt management with the proper chemotherapeutic regimen. Clinical judgement regarding the risk benefit ratio of using chemotherapeutic drugs ensures better mother and fetal outcome.

Entities:  

Keywords:  Acute leukaemia; Chemotherapy; Delivery

Year:  2014        PMID: 25478417      PMCID: PMC4253235          DOI: 10.7860/JCDR/2014/9720.5069

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  11 in total

Review 1.  Prognostic factors in adult acute lymphoblastic leukemia.

Authors:  Xavier Thomas; Quoc-Hung Le
Journal:  Hematology       Date:  2003-08       Impact factor: 2.269

Review 2.  B cell acute lymphocytic leukemia in pregnancy.

Authors:  Justin Bottsford-Miller; Sina Haeri; Arthur M Baker; Jeremiah Boles; Mark Brown
Journal:  Arch Gynecol Obstet       Date:  2010-08-18       Impact factor: 2.344

3.  Acute lymphoblastic leukaemia in pregnancy.

Authors:  J F M Molkenboer; A H Vos; H C Schouten; M C Vos
Journal:  Neth J Med       Date:  2005-10       Impact factor: 1.422

Review 4.  Acute leukemia during pregnancy: a report on 37 patients and a review of the literature.

Authors:  Youcef Chelghoum; Norbert Vey; Emmanuel Raffoux; Françoise Huguet; Arnaud Pigneux; Brigitte Witz; Cécile Pautas; Stéphane de Botton; Denis Guyotat; Bruno Lioure; Nathalie Fegueux; Frédéric Garban; Hussam Saad; Xavier Thomas
Journal:  Cancer       Date:  2005-07-01       Impact factor: 6.860

Review 5.  Issues of imatinib and pregnancy outcome.

Authors:  Jane Apperley
Journal:  J Natl Compr Canc Netw       Date:  2009-11       Impact factor: 11.908

6.  A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.

Authors:  R A Larson; R K Dodge; C P Burns; E J Lee; R M Stone; P Schulman; D Duggan; F R Davey; R E Sobol; S R Frankel
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

Review 7.  How I treat acute and chronic leukemia in pregnancy.

Authors:  Tal Shapira; David Pereg; Michael Lishner
Journal:  Blood Rev       Date:  2008-05-09       Impact factor: 8.250

8.  Leukemia in pregnancy.

Authors:  Al Sabty Firas; E Demeckova; M Mistrik
Journal:  Bratisl Lek Listy       Date:  2008       Impact factor: 1.278

Review 9.  Leukemia in pregnancy.

Authors:  C R McLain
Journal:  Clin Obstet Gynecol       Date:  1974-12       Impact factor: 2.190

10.  Acute lymphoblastic leukemia in pregnancy: a case report with literature review.

Authors:  Jonathan Ticku; Shilpa Oberoi; Sarah Friend; John Busowski; Mary Langenstroer; Said Baidas
Journal:  Ther Adv Hematol       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.